Lexaria Bioscience OverviewLexaria Bioscience EBIT
EBIT (Earnings Before Interest and Taxes) analysis for LEXX.
Quarterly EBIT
-$1.99M
↑ 46.86% YoY
As of May 31, 2026
Annual EBIT (TTM)
-$7.74M
↑ 32.05% YoY
Trailing 12 months ending May 31, 2026
Lexaria Bioscience OverviewEBIT (Earnings Before Interest and Taxes) analysis for LEXX.
As of May 31, 2026
Trailing 12 months ending May 31, 2026